First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemia

[摘要] In the paper above entitled, “First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemia” by Tang et al., published in Am J Cancer Res (2018;8(6):1083-1089), the authors would like to change the first affiliation from “Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China” to “The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Suzhou, China”. We also would like to add this corrected affiliation to the first author’s affiliation list. The correct author and affiliation information on the first page of the article should read as follows

[学科分类] 肿瘤学